CYTOKINETICS INC (CYTK)

US23282W6057 - Common Stock

59.53  -0.39 (-0.65%)

After market: 59.53 0 (0%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2024-3-31)
2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
Revenue
3.76M7.53M94.60M70.40M55.80M
Operating Expenses
501.72M503.74M418.80M256.70M149.80M
Research and Development
332.27M330.12M240.80M159.90M97.00M
Selling, General, and Administrative Expenses
169.44M173.61M178.00M96.80M52.80M
Operating Income
-497.97M-496.20M-324.20M-186.30M-93.90M
Interest Income/Expense
-32.64M-30.04M-39.80M-29.00M-33.30M
Non Recurring Items
N/A0.00-24.90MN/AN/A
Income Before Taxes
-530.60M-526.24M-389.00M-215.30M-127.30M
Income Tax
N/AN/AN/AN/A0.00
Net Income
-530.60M-526.24M-389.00M-215.30M-127.30M
EBITDA
-485.60M-484.31M-318.39M-184.02M-92.07M
 
Per Share Data
EPS Diluted Total Ops
-5.40-5.45-4.33-2.80-1.97
Non GAAP EPS
-5.40-5.45-4.22-2.83-2.01
 
Statistics
Profit Margin
-14122.94%-6988.63%-411.21%-305.82%-228.14%
Operating Profit Margin
-13254.54%-6589.71%-342.71%-264.63%-168.28%

All data in USD

Charts